In addition, hypomagnesemia, mild elevation of alanine aminotransferase, and gastrointestinal disturbances were more frequent in the bardoxolone methyl group than those in the placebo group, suggesting that bardoxolone methyl may be a promising treatment for DKD. Here, GPT is linked to familial primary hypomagnesemia.